202 related articles for article (PubMed ID: 32545682)
1. Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from
Lang PA; Parkova A; Leissing TM; Calvopiña K; Cain R; Krajnc A; Panduwawala TD; Philippe J; Fishwick CWG; Trapencieris P; Page MGP; Schofield CJ; Brem J
Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32545682
[TBL] [Abstract][Full Text] [Related]
2. Studies on the inhibition of AmpC and other β-lactamases by cyclic boronates.
Cahill ST; Tyrrell JM; Navratilova IH; Calvopiña K; Robinson SW; Lohans CT; McDonough MA; Cain R; Fishwick CWG; Avison MB; Walsh TR; Schofield CJ; Brem J
Biochim Biophys Acta Gen Subj; 2019 Apr; 1863(4):742-748. PubMed ID: 30738906
[TBL] [Abstract][Full Text] [Related]
3. Cyclic Boronates Inhibit All Classes of β-Lactamases.
Cahill ST; Cain R; Wang DY; Lohans CT; Wareham DW; Oswin HP; Mohammed J; Spencer J; Fishwick CW; McDonough MA; Schofield CJ; Brem J
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28115348
[TBL] [Abstract][Full Text] [Related]
4. Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases.
Krajnc A; Brem J; Hinchliffe P; Calvopiña K; Panduwawala TD; Lang PA; Kamps JJAG; Tyrrell JM; Widlake E; Saward BG; Walsh TR; Spencer J; Schofield CJ
J Med Chem; 2019 Sep; 62(18):8544-8556. PubMed ID: 31454231
[TBL] [Abstract][Full Text] [Related]
5. Broad Spectrum β-Lactamase Inhibition by a Thioether Substituted Bicyclic Boronate.
Parkova A; Lucic A; Krajnc A; Brem J; Calvopiña K; Langley GW; McDonough MA; Trapencieris P; Schofield CJ
ACS Infect Dis; 2020 Jun; 6(6):1398-1404. PubMed ID: 31841636
[TBL] [Abstract][Full Text] [Related]
6. The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli.
Roach EJ; Uehara T; Daigle DM; Six DA; Khursigara CM
Microbiol Spectr; 2021 Oct; 9(2):e0091821. PubMed ID: 34494877
[TBL] [Abstract][Full Text] [Related]
7. VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in
Hamrick JC; Docquier JD; Uehara T; Myers CL; Six DA; Chatwin CL; John KJ; Vernacchio SF; Cusick SM; Trout REL; Pozzi C; De Luca F; Benvenuti M; Mangani S; Liu B; Jackson RW; Moeck G; Xerri L; Burns CJ; Pevear DC; Daigle DM
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31871094
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates.
Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S
Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1
Piccirilli A; Segatore B; Brisdelli F; Amicosante G; Perilli M
Int J Antimicrob Agents; 2021 Jan; 57(1):106228. PubMed ID: 33246038
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of the novel β-lactamase inhibitor taniborbactam (VNRX-5133), in combination with cefepime or meropenem, against MDR Gram-negative bacterial isolates from China.
Wang X; Zhao C; Wang Q; Wang Z; Liang X; Zhang F; Zhang Y; Meng H; Chen H; Li S; Zhou C; Li H; Wang H
J Antimicrob Chemother; 2020 Jul; 75(7):1850-1858. PubMed ID: 32154866
[TBL] [Abstract][Full Text] [Related]
11.
Lomovskaya O; Castanheira M; Lindley J; Rubio-Aparicio D; Nelson K; Tsivkovski R; Sun D; Totrov M; Loutit J; Dudley M
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0044023. PubMed ID: 37800963
[TBL] [Abstract][Full Text] [Related]
12. Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.
Zhanel GG; Lawrence CK; Adam H; Schweizer F; Zelenitsky S; Zhanel M; Lagacé-Wiens PRS; Walkty A; Denisuik A; Golden A; Gin AS; Hoban DJ; Lynch JP; Karlowsky JA
Drugs; 2018 Jan; 78(1):65-98. PubMed ID: 29230684
[TBL] [Abstract][Full Text] [Related]
13. Profiling interactions of vaborbactam with metallo-β-lactamases.
Langley GW; Cain R; Tyrrell JM; Hinchliffe P; Calvopiña K; Tooke CL; Widlake E; Dowson CG; Spencer J; Walsh TR; Schofield CJ; Brem J
Bioorg Med Chem Lett; 2019 Aug; 29(15):1981-1984. PubMed ID: 31171422
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Development of (1-(3'-Mercaptopropanamido)methyl)boronic Acid Derived Broad-Spectrum, Dual-Action Inhibitors of Metallo- and Serine-β-lactamases.
Wang YL; Liu S; Yu ZJ; Lei Y; Huang MY; Yan YH; Ma Q; Zheng Y; Deng H; Sun Y; Wu C; Yu Y; Chen Q; Wang Z; Wu Y; Li GB
J Med Chem; 2019 Aug; 62(15):7160-7184. PubMed ID: 31269398
[TBL] [Abstract][Full Text] [Related]
15. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of metallo-β-lactamase resistance to taniborbactam.
Drusin SI; Le Terrier C; Poirel L; Bonomo RA; Vila AJ; Moreno DM
Antimicrob Agents Chemother; 2024 Feb; 68(2):e0116823. PubMed ID: 38063400
[TBL] [Abstract][Full Text] [Related]
17. Biochemical Activity of Vaborbactam.
Tsivkovski R; Lomovskaya O
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712199
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.
Brem J; Cain R; Cahill S; McDonough MA; Clifton IJ; Jiménez-Castellanos JC; Avison MB; Spencer J; Fishwick CW; Schofield CJ
Nat Commun; 2016 Aug; 7():12406. PubMed ID: 27499424
[TBL] [Abstract][Full Text] [Related]
19. Will morphing boron-based inhibitors beat the β-lactamases?
Krajnc A; Lang PA; Panduwawala TD; Brem J; Schofield CJ
Curr Opin Chem Biol; 2019 Jun; 50():101-110. PubMed ID: 31004962
[TBL] [Abstract][Full Text] [Related]
20. Vaborbactam: Spectrum of Beta-Lactamase Inhibition and Impact of Resistance Mechanisms on Activity in Enterobacteriaceae.
Lomovskaya O; Sun D; Rubio-Aparicio D; Nelson K; Tsivkovski R; Griffith DC; Dudley MN
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
